metastron 37 mbq
ge healthcare limited - marea britanie - stronȚiu cloride - sol. inj. - 37 mbq/ml - trat. paliativ al durerii (preparate pentru sistemul osos) diferite radiofarmaceutice pt.trat. paliativ al durerii
dotagraf 0,5 mmol/ml
sanochemia pharmazeutika gmbh - austria - acid gadotericum - sol. inj. in flac. multidoza - 0,5mmol/ml - contrast media-rezonanta magnetica medii de contrast paramagnetice
fdg-rmc 185 mbq/ml
ruder medikol ciklotron d.o.o. - croatia - fludeoxiglucoza (18f) - sol. inj. - 185mbq/ml - preparate pentru detectarea tumorilor alte radiofarmaceutice pt. detectarea tumorilor
gadovist 1,0 mmol/ml
bayer ag - germania - gadobutrolum - sol inj. in seringa preumpluta - 1,0mmol/ml - contrast media-rezonanta magnetica medii de contrast paramagnetice
gadovist 1,0 mmol/ml
bayer ag - germania - gadobutrolum - sol. inj. - 1,0mmol/ml - contrast media-rezonanta magnetica medii de contrast paramagnetice
memovist 1 mmol/ml
bayer ag - germania - gadobutrolum - sol. inj. in seringa preumpluta - 1mmol/ml - contrast media-rezonanta magnetica medii de contrast paramagnetice
byooviz
samsung bioepis nl b.v. - ranibizumab - wet macular degeneration; macular edema; diabetic retinopathy; myopia, degenerative - oftalmologice - byooviz is indicated in adults for:the treatment of neovascular (wet) age-related macular degeneration (amd)the treatment of visual impairment due to diabetic macular oedema (dme)the treatment of proliferative diabetic retinopathy (pdr)the treatment of visual impairment due to macular oedema secondary to retinal vein occlusion (branch rvo or central rvo)the treatment of visual impairment due to choroidal neovascularisation (cnv).
ximluci
stada arzneimittel ag - ranibizumab - wet macular degeneration; macular edema; diabetic retinopathy; diabetes complications - oftalmologice - ximluci is indicated in adults for:the treatment of neovascular (wet) age-related macular degeneration (amd)the treatment of visual impairment due to diabetic macular oedema (dme)the treatment of proliferative diabetic retinopathy (pdr)the treatment of visual impairment due to macular oedema secondary to retinal vein occlusion (branch rvo or central rvo)the treatment of visual impairment due to choroidal neovascularisation (cnv).
ranivisio
midas pharma gmbh - ranibizumab - wet macular degeneration; macular edema; diabetic retinopathy; diabetes complications - oftalmologice - ranivisio is indicated in adults for:• the treatment of neovascular (wet) age-related macular degeneration (amd)• the treatment of visual impairment due to diabetic macular oedema (dme)• the treatment of proliferative diabetic retinopathy (pdr)• the treatment of visual impairment due to macular oedema secondary to retinal vein occlusion (branch rvo or central rvo)• the treatment of visual impairment due to choroidal neovascularisation (cnv).
lactinette - richter 0,075 mg comprimate filmate
gedeon richter plc - desogestrelum - comprimate filmate - 0,075 mg